Skip to content

Comparative Study Of Marma And Agnikarma In The Pain Management Of Sciatica

Compative Study Of Efficacy Of Marma Chikitsa And Agnikarma In The Pain Management Of Gradhrasi(Sciatica) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080187
Enrollment
30
Registered
2025-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G541- Lumbosacral plexus disorders

Interventions

None listed

Sponsors

Pt Khushilal Sharma Govt Auto Ayurveda College And Institute Bhopal Madhya Pradesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of either sex in the age group of 20 to 60 years. 2.Clinical signs and symptoms of gradhrasi present in the classical text 3.Tenderness at the course of Sciatic Nerve. 4.Severe pain on squatting. 5. Patient willing to be registered for study.

Exclusion criteria

Exclusion criteria: 1.Fracture related to spine and lower limb 2.Patients who are suffering from any systemic or metabolic disorders 3.Traumatic Infective Neoplastic conditions of spine 4.Patient having Hemoglobin less then 07.00 mg/dl 5.Cardiac diseases 6.Pregnant and lactating women 7.Patient having any hematological and bleeding disorder

Design outcomes

Primary

MeasureTime frame
It Is Expected That At The End Of Study Scholar Will Be Able To Evaluate The Effect Of Marma Chikitsa And Agnikarma In The Pain Management Of Gradhrasi(Sciatica).Timepoint: 21 Days

Secondary

MeasureTime frame
Marma Chikitsa Is a Non Pharmaceutical Approach To Manage Pain In Gradhrasi(Sciatica).Timepoint: 21 Days

Countries

India

Contacts

Public ContactDr Anjali Sadani

Pt Khushilal Sharma Govt.(Auto) Ayurveda College and Institute Bhopal Madhya Pradesh.

marwaharita@gmail.com9425679777

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026